세계의 세포 및 유전자 치료 공급망과 물류 시장 보고서(2025년)

Cell and gene therapy supply chain and logistics encompass the systematic coordination and management of materials, information, and resources essential for the development, production, and distribution of cell and gene therapies, ensuring their safe and effective administration to patients. These services deliver advanced treatments to patients, upholding the highest standards of safety and efficacy throughout the entire supply chain.

Various software solutions play crucial roles in these processes, including cell orchestration platforms, enterprise manufacturing systems, inventory management systems, laboratory information management systems, logistics management systems, patient management systems, quality management systems, and tracking and tracing systems. A cell orchestration platform is a software or technological platform facilitating the coordination, management, and integration of diverse processes related to cell therapy development, manufacturing, and delivery. It streamlines and automates tasks associated with cell sourcing, manufacturing, quality control, logistics, patient tracking, and data management. These platforms are deployed as cloud-based or on-premises solutions and are utilized in cryogenic shippers, cryogenic storage freezers, ultra-low freezers, cold chain management systems, shipment, storage medium, cryogenic packout kits, and other components. Applications include donor eligibility assessment, sample collection, manufacturing, logistics, patient verification, and treatment follow-up. End-users encompass biobanks, cell therapy labs, hospitals, research institutes, and commercial organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The cell and gene therapy supply chain/logistics research report is one of a series of new reports from The Business Research Company that provides cell and gene therapy supply chain/logistics market statistics, including the cell and gene therapy supply chain/logistics industry's global market size, regional shares, competitors with a cell and gene therapy supply chain/logistics market share, detailed cell and gene therapy supply chain/logistics market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy supply chain/logistics industry. This cell and gene therapy supply chain/logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell and gene therapy supply chain/logistics market size has grown rapidly in recent years. It will grow from $1.41 billion in 2024 to $1.57 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to growth in prevalence of chronic diseases, efficient use of supply chain requirements, rise in maintenance the drug integrity, evolved regulatory frameworks, increased emphasis on risk mitigation and compliance.

The cell and gene therapy supply chain/logistics market size is expected to see rapid growth in the next few years. It will grow to $2.44 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to expansion of personalized medicine, development of cell-free therapies, growing prevalence of chronic diseases, growing global cell therapy manufacturing market, efficient use of supply chain requirements. Major trends in the forecast period include increased research and development expenditure, adoption of advanced technologies, favorable initiatives and programs for easier access, partnerships and collaborations between cell and gene therapy companies, supply chain providers, and logistics companies, providing of customizable services to support any point of patient identification.

The forecast of 11.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose critical challenges for U.S. therapies by restricting access to cryogenic shipping containers and temperature-monitoring devices imported from the Netherlands and Sweden, potentially compromising $2M+ cell therapy shipments. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing demand for cell and gene therapies is propelling the cell and gene therapy supply chain and logistics market. These advanced medical treatments modify cells or genes to address diseases, offering potential breakthroughs for previously untreatable conditions. Proper temperature and storage conditions are crucial for these therapies, which supply chain and logistics services can provide through sourcing, distribution, and storage solutions. For example, the American Society of Gene & Cell Therapy, a US-based non-profit organization, reported a 10% increase in the number of gene therapies in Phase III clinical trials in Q3 2023, marking the first quarterly rise since Q3 2022. As a result, the increasing demand for cell and gene therapies is driving the growth of the cell and gene therapy supply chain and logistics market.

The anticipated growth of the cell and gene therapy supply chain/logistics market is further supported by the increasing demand for personalized medicine. Personalized medicine involves tailoring medical decisions, interventions, and drug therapies to individual patients, and the supply chain/logistics services for cell and gene therapies play a critical role in delivering these precision medicines safely and effectively. Temperature monitoring is incorporated to maintain integrity throughout the supply chain. As of October 2022, there were over 75,000 genetic testing products and 300 personalized medicines, highlighting the growing demand for personalized medical solutions, according to reports published by STAT, a US-based health-oriented news company. Therefore, the rising demand for personalized medicine is a key driver of the growth in the cell and gene therapy supply chain/logistics market.

The adoption of modern technology platforms stands out as a key trend in the cell and gene therapy supply chain/logistics markets. Major companies within this sector are actively developing advanced technology platforms to enhance their position in the market. For instance, in April 2023, AmerisourceBergen Corporation, a US-based healthcare company specializing in cell and gene therapy supply chain logistics, introduced the Cell and Gene Therapy (CGT) Integration Hub. This innovative hub, powered by AmerisourceBergen's customer relationship management (CRM) system, can seamlessly integrate into the biopharma platform, enabling improved monitoring of the development and delivery processes for cell and gene therapies.

Leading companies in the cell and gene therapy supply chain/logistics sector are concentrating on introducing next-generation solutions, including off-the-shelf cell orchestration platforms. These platforms offer streamlined supply chain management, pre-designed modules, industry-proven processes, rapid deployment, and integration capabilities. For example, in January 2022, TrakCel Limited, a UK-based software company, launched OCELLOS Lite, a pre-designed, modular, and validated solution for managing the supply chain and logistics of cell and gene therapies. OCELLOS Lite facilitates supply chain process management from clinical development phases to commercialization and boasts quick deployment, making it one of the most straightforward and rapid solutions.

In April 2022, Cryoport Systems LLC, a US-based provider of temperature-controlled logistics services, acquired Cell&Co BioServices for $6.2 million. This strategic acquisition enabled Cryoport to expand its global supply chain network and better cater to the needs of the regenerative medicine industry. Cell&Co BioServices, based in France, is a supply chain management services provider for biological, pharmaceutical, and clinical samples throughout their life cycle.

Major companies operating in the cell and gene therapy supply chain/logistics market include AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.

North America was the largest region in the cell and gene therapy supply chain/logistics market in 2024. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cell and gene therapy supply chain/logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The cell and gene therapy supply chain and logistics market includes revenues earned by entities by providing sourcing and collection, quality testing, distribution, and transportation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell and gene therapy supply chain/logistics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell and gene therapy supply chain/logistics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell and gene therapy supply chain/logistics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type Of Software Solution: Cell Orchestration Platform; Enterprise Manufacturing System; Inventory Management System; Laboratory Information Management System; Logistics Management System; Patient Management System; Quality Management System; Tracking And Tracing System
• 2) By Mode Of Deployment: Cloud-Based Solution; On-Premises Solution
• 3) By Component: Cryogenic Shippers; Cryogenic Storage Freezers; Ultra-Low Freezers; Cold Chain Management Systems; Shipment; Storage Medium; Cryogenic Packout Kits; Other Components
• 4) By Application Area: Donor Eligibility Assessment; Sample Collection; Manufacturing; Logistics; Patient Verification; Treatment Follow-Up
• 5) By End User: Biobank; Cell Therapy Lab; Hospital; Research Institute; Commercial Organization
• Subsegments:
• 1) By Cell Orchestration Platform: Workflow Management; Scheduling And Coordination Tools
• 2) By Enterprise Manufacturing System: Production Planning And Control; Manufacturing Execution Systems (MES)
• 3) By Inventory Management System: Stock Tracking And Management; Inventory Forecasting And Optimization
• 4) By Laboratory Information Management System (LIMS): Sample Tracking And Management; Data Management And Reporting
• 5) By Logistics Management System: Route Optimization And Planning; Transportation Management
• 6) By Patient Management System: Patient Scheduling And Coordination; Data Management And Tracking Of Patient Outcomes
• 7) By Quality Management System: Compliance Tracking; Quality Assurance And Control
• 8) By Tracking And Tracing System: Real-Time Tracking Of Shipments; Chain Of Custody Documentation
• Companies Mentioned: AmerisourceBergen Corporation; United Parcel Service; Thermo Fisher Scientific Inc.; Avantor Sciences; Lonza Group AG; Arvato Group; Catalent Inc.; Charles River Laboratories International; Parexel International Corporation; Cytiva; Almac Group; World Courier; Sharp Packaging Services; PCI Pharma Services; Cryoport Inc.; Brooks Life Sciences; BioLife Solutions Inc.; Biocair Inc.; QuickSTAT; Clarkston Consulting Inc.; Central Pharma; TrakCel limited; MAK-SYSTEM International Group; Hypertrust Patient Data Care GmbH; Atelerix Ltd.; Polar Express Transportation; Be The Match BioTherapies Inc.; Yourway Biopharma Services Company; Azenta Life Sciences Inc.; Biostor Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell And Gene Therapy Supply Chain/Logistics Market Characteristics

3. Cell And Gene Therapy Supply Chain/Logistics Market Trends And Strategies

4. Cell And Gene Therapy Supply Chain/Logistics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cell And Gene Therapy Supply Chain/Logistics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cell And Gene Therapy Supply Chain/Logistics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cell And Gene Therapy Supply Chain/Logistics Market Growth Rate Analysis
• 5.4. Global Cell And Gene Therapy Supply Chain/Logistics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cell And Gene Therapy Supply Chain/Logistics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cell And Gene Therapy Supply Chain/Logistics Total Addressable Market (TAM)

6. Cell And Gene Therapy Supply Chain/Logistics Market Segmentation

• 6.1. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Orchestration Platform
• Enterprise Manufacturing System
• Inventory Management System
• Laboratory Information Management System
• Logistics Management System
• Patient Management System
• Quality Management System
• Tracking And Tracing System
• 6.2. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloud-Based Solution
• On-Premises Solution
• 6.3. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cryogenic Shippers
• Cryogenic Storage Freezers
• Ultra-Low Freezers
• Cold Chain Management Systems
• Shipment
• Storage Medium
• Cryogenic Packout Kits
• Other Components
• 6.4. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Donor Eligibility Assessment
• Sample Collection
• Manufacturing
• Logistics
• Patient Verification
• Treatment Follow-Up
• 6.5. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biobank
• Cell Therapy Lab
• Hospital
• Research Institute
• Commercial Organization
• 6.6. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Cell Orchestration Platform, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Workflow Management
• Scheduling And Coordination Tools
• 6.7. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Enterprise Manufacturing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Production Planning And Control
• Manufacturing Execution Systems (MES)
• 6.8. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Inventory Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stock Tracking And Management
• Inventory Forecasting And Optimization
• 6.9. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Laboratory Information Management System (LIMS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sample Tracking And Management
• Data Management And Reporting
• 6.10. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Logistics Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Route Optimization And Planning
• Transportation Management
• 6.11. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Patient Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Patient Scheduling And Coordination
• Data Management And Tracking Of Patient Outcomes
• 6.12. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Quality Management System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Compliance Tracking
• Quality Assurance And Control
• 6.13. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Tracking And Tracing System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Real-Time Tracking Of Shipments
• Chain Of Custody Documentation

7. Cell And Gene Therapy Supply Chain/Logistics Market Regional And Country Analysis

• 7.1. Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market

• 8.1. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell And Gene Therapy Supply Chain/Logistics Market

• 9.1. China Cell And Gene Therapy Supply Chain/Logistics Market Overview
• 9.2. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell And Gene Therapy Supply Chain/Logistics Market

• 10.1. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell And Gene Therapy Supply Chain/Logistics Market

• 11.1. Japan Cell And Gene Therapy Supply Chain/Logistics Market Overview
• 11.2. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell And Gene Therapy Supply Chain/Logistics Market

• 12.1. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market

• 13.1. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell And Gene Therapy Supply Chain/Logistics Market

• 14.1. South Korea Cell And Gene Therapy Supply Chain/Logistics Market Overview
• 14.2. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market

• 15.1. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market Overview
• 15.2. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell And Gene Therapy Supply Chain/Logistics Market

• 16.1. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell And Gene Therapy Supply Chain/Logistics Market

• 17.1. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell And Gene Therapy Supply Chain/Logistics Market

• 18.1. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell And Gene Therapy Supply Chain/Logistics Market

• 19.1. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell And Gene Therapy Supply Chain/Logistics Market

• 20.1. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market

• 21.1. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market Overview
• 21.2. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell And Gene Therapy Supply Chain/Logistics Market

• 22.1. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell And Gene Therapy Supply Chain/Logistics Market

• 23.1. North America Cell And Gene Therapy Supply Chain/Logistics Market Overview
• 23.2. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell And Gene Therapy Supply Chain/Logistics Market

• 24.1. USA Cell And Gene Therapy Supply Chain/Logistics Market Overview
• 24.2. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell And Gene Therapy Supply Chain/Logistics Market

• 25.1. Canada Cell And Gene Therapy Supply Chain/Logistics Market Overview
• 25.2. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell And Gene Therapy Supply Chain/Logistics Market

• 26.1. South America Cell And Gene Therapy Supply Chain/Logistics Market Overview
• 26.2. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell And Gene Therapy Supply Chain/Logistics Market

• 27.1. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell And Gene Therapy Supply Chain/Logistics Market

• 28.1. Middle East Cell And Gene Therapy Supply Chain/Logistics Market Overview
• 28.2. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell And Gene Therapy Supply Chain/Logistics Market

• 29.1. Africa Cell And Gene Therapy Supply Chain/Logistics Market Overview
• 29.2. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell And Gene Therapy Supply Chain/Logistics Market Competitive Landscape And Company Profiles

• 30.1. Cell And Gene Therapy Supply Chain/Logistics Market Competitive Landscape
• 30.2. Cell And Gene Therapy Supply Chain/Logistics Market Company Profiles
  • 30.2.1. AmerisourceBergen Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. United Parcel Service Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Avantor Sciences Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

31. Cell And Gene Therapy Supply Chain/Logistics Market Other Major And Innovative Companies

• 31.1. Arvato Group
• 31.2. Catalent Inc.
• 31.3. Charles River Laboratories International
• 31.4. Parexel International Corporation
• 31.5. Cytiva
• 31.6. Almac Group
• 31.7. World Courier
• 31.8. Sharp Packaging Services
• 31.9. PCI Pharma Services
• 31.10. Cryoport Inc.
• 31.11. Brooks Life Sciences
• 31.12. BioLife Solutions Inc.
• 31.13. Biocair Inc.
• 31.14. QuickSTAT
• 31.15. Clarkston Consulting Inc.

32. Global Cell And Gene Therapy Supply Chain/Logistics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell And Gene Therapy Supply Chain/Logistics Market

34. Recent Developments In The Cell And Gene Therapy Supply Chain/Logistics Market

35. Cell And Gene Therapy Supply Chain/Logistics Market High Potential Countries, Segments and Strategies

• 35.1 Cell And Gene Therapy Supply Chain/Logistics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cell And Gene Therapy Supply Chain/Logistics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cell And Gene Therapy Supply Chain/Logistics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer